» Articles » PMID: 35780086

Diffuse Myometrium Thinning and Placenta Accreta Spectrum in a Patient with Systemic Lupus Erythematosus (SLE): a Case Report and Review of the Literature

Overview
Publisher Biomed Central
Date 2022 Jul 2
PMID 35780086
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cases of uterine wall thinning and placental abnormalities complicated with systemic lupus erythematosus (SLE) during pregnancy have been reported in Asian countries for ten years. Long-term steroid use can cause muscle degeneration, but the mechanism of myometrium thinning was not known. Through the review of published articles, this report is the first review of cases to discuss the pathogenesis and clinical features of thinned myometrium and placenta accreta spectrum (PAS) in pregnant patients with SLE.

Case Presentation: A twenty-nine-year-old primigravida with a history of lupus enteritis and paralytic ileus had a natural conception after less than two years of steroid treatment. An ultrasonographic study showed a thin uterine wall with a widespread thick placenta on the entire surface of the uterine cavity in the third trimester. At the 39th gestational week, she underwent a cesarean section due to the failure of the uterus to contract, even though the injection of oxytocin. There were several engorged vessels on the surface of the anterior uterine wall at the time of laparotomy. We decided to perform a hysterectomy because diffuse PAS replaced her uterus.

Conclusion: A review of reported cases and our case shows an unusual complication of SLE that might be related to the particular condition of the estrogen-mediated immune system. Clinicians should always pay attention to the possibility of uterine wall thinning as uterine atony and the structural abnormality of the placenta for SLE patients with the unscarred uterus.

Citing Articles

Conservative Management of Placenta Percreta With Perforation in an Infertile Lupus Patient Following Embryo Transfer: A Report of a Rare Case.

Sugihara M, Ota K, Takahashi T, Tasaka K, Okamoto H, Morimoto Y Cureus. 2024; 16(11):e74774.

PMID: 39735005 PMC: 11682835. DOI: 10.7759/cureus.74774.


Evaluation of the holding-up uterus technique for placenta accreta spectrum cesarean hysterectomy in shocked patients with a high shock index: a case series study.

Takahashi J, Orisaka M, Inoue D, Kawamura H, Takahashi N, Tsuyoshi H BMC Surg. 2024; 24(1):23.

PMID: 38218800 PMC: 10787967. DOI: 10.1186/s12893-024-02311-8.


Extensive fundal placenta accreta spectrum (PAS) in a nulliparous patient with an unscarred uterus and systemic lupus erythematosus (SLE) necessitating cesarean hysterectomy at delivery.

Sherer D, Thompson M, Field A, Granderson F, Dalloul M Radiol Case Rep. 2023; 18(11):4057-4061.

PMID: 37701359 PMC: 10493878. DOI: 10.1016/j.radcr.2023.08.061.

References
1.
Jakobsen I, Helmig R, Stengaard-Pedersen K . Maternal and foetal outcomes in pregnant systemic lupus erythematosus patients: an incident cohort from a stable referral population followed during 1990-2010. Scand J Rheumatol. 2015; 44(5):377-84. DOI: 10.3109/03009742.2015.1013982. View

2.
Ramires de Jesus G, Mendoza-Pinto C, de Jesus N, Dos Santos F, Klumb E, Garcia Carrasco M . Understanding and Managing Pregnancy in Patients with Lupus. Autoimmune Dis. 2015; 2015:943490. PMC: 4515284. DOI: 10.1155/2015/943490. View

3.
Rabin D, Johnson E, Brandon D, Liapi C, Chrousos G . Glucocorticoids inhibit estradiol-mediated uterine growth: possible role of the uterine estradiol receptor. Biol Reprod. 1990; 42(1):74-80. DOI: 10.1095/biolreprod42.1.74. View

4.
Hernandez-Rodriguez J, Tan C, Rodriguez E, Hoffman G . Gynecologic vasculitis: an analysis of 163 patients. Medicine (Baltimore). 2009; 88(3):169-181. DOI: 10.1097/MD.0b013e3181a577f3. View

5.
Noh J, Park C, Jo M, Kwon J . Rupture of an unscarred uterus in a woman with long-term steroid treatment for systemic lupus erythematosus. Obstet Gynecol. 2013; 122(2 Pt 2):472-475. DOI: 10.1097/AOG.0b013e3182998fb6. View